Wyeth/Pfizer Update: Analysts Comment on Potential Acquisition
On Jan. 26, 2009, Pfizer and Wyeth entered into a definitive merger agreement valued at approximately $68 billion. Analysts from AMR Research and Argus Research companies discuss the details of the possible transaction.